rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
2 Pt 1
|
pubmed:dateCreated |
2007-1-26
|
pubmed:abstractText |
Neurofibromatosis type 1 (NF1) is an autosomal dominant disorder with a complex variety of clinical manifestations. The hallmark of NF1 is the onset of heterogeneous (dermal or plexiform) benign neurofibromas. Plexiform neurofibromas can give rise to malignant peripheral nerve sheath tumors, which are resistant to conventional therapies.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
1078-0432
|
pubmed:author |
pubmed-author:BiècheIvanI,
pubmed-author:DessenPhilippeP,
pubmed-author:LévyPascaleP,
pubmed-author:LaurendeauIngridI,
pubmed-author:LazarVladimirV,
pubmed-author:LeroyKarenK,
pubmed-author:OrtonneNicolasN,
pubmed-author:ParfaitBéatriceB,
pubmed-author:RipocheHuguesH,
pubmed-author:SalmonIsabelleI,
pubmed-author:VidaudDominiqueD,
pubmed-author:VidaudMichelM,
pubmed-author:WechslerJanineJ,
pubmed-author:WolkensteinPierreP
|
pubmed:issnType |
Print
|
pubmed:day |
15
|
pubmed:volume |
13
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
398-407
|
pubmed:meshHeading |
pubmed-meshheading:17202312-Alternative Splicing,
pubmed-meshheading:17202312-Cell Differentiation,
pubmed-meshheading:17202312-Cluster Analysis,
pubmed-meshheading:17202312-Fibroblasts,
pubmed-meshheading:17202312-Gene Expression Regulation, Neoplastic,
pubmed-meshheading:17202312-Humans,
pubmed-meshheading:17202312-Neurofibromatosis 1,
pubmed-meshheading:17202312-Oligonucleotide Array Sequence Analysis,
pubmed-meshheading:17202312-Signal Transduction,
pubmed-meshheading:17202312-Tenascin,
pubmed-meshheading:17202312-Treatment Outcome
|
pubmed:year |
2007
|
pubmed:articleTitle |
Microarray-based identification of tenascin C and tenascin XB, genes possibly involved in tumorigenesis associated with neurofibromatosis type 1.
|
pubmed:affiliation |
Laboratoire de Génétique Moléculaire-Institut National de la Sante et de la Recherche Medicale U745, Faculté des Sciences Pharmaceutiques et Biologiques, Université Paris V, 4 avenue de l'Observatoire, Paris, France.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|